SYNDAX PHARMACEUTICALS INC's ticker is and the CUSIP is 87164F955. A total of 3 filers reported holding SYNDAX PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,384,704 | +4069.4% | 715,200 | +5910.1% | 0.04% | +3400.0% |
| Q2 2023 | $249,067 | +24.1% | 11,900 | +25.3% | 0.00% | 0.0% |
| Q1 2023 | $200,640 | -30.8% | 9,500 | -16.7% | 0.00% | 0.0% |
| Q4 2022 | $290,130 | +14406.5% | 11,400 | +11300.0% | 0.00% | – |
| Q1 2022 | $2,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q4 2021 | $2,000 | -98.1% | 100 | -98.4% | 0.00% | – |
| Q2 2021 | $108,000 | +5300.0% | 6,300 | +6200.0% | 0.00% | – |
| Q1 2021 | $2,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q4 2020 | $2,000 | -98.9% | 100 | -99.2% | 0.00% | -100.0% |
| Q3 2020 | $186,000 | +64.6% | 12,600 | +65.8% | 0.00% | 0.0% |
| Q2 2020 | $113,000 | +1030.0% | 7,600 | +744.4% | 0.00% | – |
| Q1 2020 | $10,000 | -88.9% | 900 | -91.2% | 0.00% | -100.0% |
| Q4 2019 | $90,000 | +143.2% | 10,200 | +104.0% | 0.00% | – |
| Q3 2019 | $37,000 | -33.9% | 5,000 | -16.7% | 0.00% | -100.0% |
| Q2 2019 | $56,000 | +143.5% | 6,000 | +39.5% | 0.00% | – |
| Q1 2019 | $23,000 | +21.1% | 4,300 | 0.0% | 0.00% | – |
| Q4 2018 | $19,000 | -85.6% | 4,300 | -73.6% | 0.00% | -100.0% |
| Q3 2018 | $132,000 | +1785.7% | 16,300 | +1530.0% | 0.00% | – |
| Q2 2018 | $7,000 | 0.0% | 1,000 | +100.0% | 0.00% | – |
| Q1 2018 | $7,000 | -22.2% | 500 | -50.0% | 0.00% | – |
| Q4 2017 | $9,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 6,000 | $56,000 | 0.00% |
| SIMPLEX TRADING, LLC | 27 | $25,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |